Altamira Therapeutics Ltd. (CYTOF) Free cash flow
Altamira Therapeutics Ltd. (CYTOF) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$6.2MFY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$6.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CYTOF financial trends
CYTOF RevenueCYTOF Net incomeCYTOF Net marginCYTOF Gross profitCYTOF Gross marginCYTOF Operating incomeCYTOF Operating marginCYTOF Operating cash flowCYTOF Capital expendituresCYTOF Return on equityCYTOF Stock buybacksCYTOF Dividends paidCYTOF Total assetsCYTOF Total liabilitiesCYTOF Shareholders’ equityCYTOF overview →